A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This four-period, single-center, open-label, single-dose, randomized, cross-over study will assess the bioequivalence and safety of an oral solution of Copegus (ribavirin) compared to a Copegus tablet in healthy adult volunteers. Volunteers will be randomized to one of four sequences in which they will receive the treatment under fed and under fasted conditions.
Epistemonikos ID: ba51e6ea30d065f25b3d89ad442726b0d794c2d1
First added on: May 11, 2024